Search for management index of systemic edema experienced by breast cancer patients on taxane drug treatment

Search for management index of systemic edema experienced by breast cancer patients on taxane drug treatment - Search for management index of systemic edema experienced by breast cancer patients on taxane drug treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036907

Enrollment

Registered

2019-06-01

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Nutritional guidance for taste disorders that appear during taxane therapy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Adult patients over 20 years of age who use taxane drugs in breast cancer patients 2) Patients judged by attending physicians to be able to participate in research 3) If there is heart disease including kidney disease or hypertension, taking diuretic Even if the treatment can be carried out including the medical history

Exclusion criteria

Exclusion criteria: 1) Patients who have seen edema in their extremities before treatment 2) Patients who are mentally unstable

Design outcomes

Primary

Measure	Time frame
Occurrence frequency of edema during the period from administration of taxane drug to the end of administration	—

Secondary

Measure	Time frame
QOL of breast cancer patients during the period from administration of taxane drugs to the end of administration	—

Countries

Japan

Contacts

Public Contacttomoko IZAWA

Graduate school of Medicine kyoto university department of human health science

tizawa@kuhp.kyoto-u.ac.jp0757513971

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026